Evidence map›Paper›PMID 37286895›Full record

ReviewJournal of human genetics2023

Is legislation to prevent genetic discrimination necessary in Japan? An overview of the current policies and public attitudes.

Kaori Muto, Akiko Nagai, Izen Ri, Kyoko Takashima, Sachie Yoshida

Erratum issuedAbstract readReview
In one paragraph

Review in Journal of human genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Kaori Muto *Department of Public Policy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan. krmt@ims.u-tokyo.ac.jp.
Akiko Nagai *Department of Public Policy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.
Izen RiDepartment of Public Policy, The Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan.ORCID http://orcid.org/0000-0002-8598-5368
Kyoko TakashimaBioethics Section, Center for Clinical Sciences, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Sachie YoshidaDepartment of Biomedical Ethics, Kyoto Prefectural University of Medicine, Kyoto City, Kyoto, Japan.

Funding

Japan Agency for Medical Research and Development (AMED) JP16cm0106001Japan Agency for Medical Research and Development (AMED) JP20bm0904002MEXT | Japan Society for the Promotion of Science (JSPS) JP15H05913MEXT | Japan Society for the Promotion of Science (JSPS) JP18K09940Ministry of Health, Labour and Welfare (Ministry of Health, Labour and Welfare, Japan) JPMH16CA2020
6 · The paper itself

Abstract

Genetic discrimination (GD) has not been discussed in East Asia as extensively as in Europe and North America. Influenced by UNESCO's universal declaration in 1997, the Japanese government took a stringent approach toward GD by releasing the Basic Principles on Human Genome Research in 2000. However, Japanese society has mostly been ignoring the prevention of GD for decades, and the principle of prohibiting GD was never adhered to in any of the Japanese laws. We conducted anonymous surveys among the general adult population in 2017 and 2022 to explore their experiences of GD and attitudes toward laws carrying penalties to prevent GD in Japan. In both years, approximately 3% of the respondents had experienced some unfavorable treatment regarding their genetic information. They showed higher recognition of the benefits of using genetic information and lower recognition of concerns about using genetic information and GD in 2022 than in 2017. However, the awareness regarding the need for legislation with penalties on GD had increased over the five-year period. In 2022, the framework of a bill to promote genomic medicine and prevent GD without any relevant penalties was released by the Bipartisan Diet Members Caucus. Considering that the absence of regulations may be a barrier to obtaining genomic medicine, as the initial step toward making the prohibition of GD more effective, legislation that no form of GD will be tolerated may stimulate education and awareness regarding respect for the human genome and its diversity.

Indexed as

PolicyPublic OpinionAdultAsia, EasternAttitudeHumansJapan

Identifiers

PMID37286895
PMCPMC10449614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.